Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05066009 · ClinicalTrials.gov registry record · NA
Sleep/Wake State Assessment with Non-invasive Earbuds
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05066009: Completed NA study, sponsored by Emory University.
NCT05066009 is a NA study that has completed, run by Emory University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05066009, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study is a within subject's assessment of whether a novel wearable technology, NextSense electroencephalography earbuds (EEGBuds), is able to detect differences in onset to sleep from wake versus in-laboratory, gold-standard electroencephalography (EEG) utilized as part of a standard four trial Maintenance of Wakefulness Test (MWT) at medicated baseline versus free of prescribed medications for promoting wake (random order).
Primary Outcome
Sleep onset latency is the time in minutes it takes to transition from wakefulness to sleep. Within-individual change in the mean onset to sleep will be assessed from the two MWT sessions performed as detected by NextSense EEGBuds.
Interventions
- DEVICE NextSense EEG-enabled earbuds
- DEVICE Ellcie Healthy eyeglasses
- OTHER Drug Holiday
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-10-13 |
| Est. Completion | 2023-10-27 |
| Phase | NA |
What the finished NCT05066009 record still lists
NCT05066009 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which NextSense EEG-enabled earbuds is the first listed.
NCT05066009 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05066009 about?
NCT05066009 is a clinical study titled "Sleep/Wake State Assessment with Non-invasive Earbuds". This study is a within subject's assessment of whether a novel wearable technology, NextSense electroencephalography earbuds (EEGBuds), is able to detect differences in onset to sleep from wake versus in-laboratory, gold-standard electroencephalography (EEG) utilized as part of a standard four trial...
What is the current status of trial NCT05066009?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2021-10-13. Estimated completion is 2023-10-27.
What interventions are being tested in trial NCT05066009?
The interventions under investigation include: NextSense EEG-enabled earbuds (DEVICE), Ellcie Healthy eyeglasses (DEVICE), Drug Holiday (OTHER).
Who is sponsoring clinical trial NCT05066009?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05066009's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI